ICON Public Limited Company
Sector
Location
Market Cap
USD 13.15 B
Share Price
USD 169.08
Avg Daily Volume
1,392,651
Change (1 day)
Change (1 year)
Change (YTD)
Eli Lilly and Company
USD 639.43
LLY
AbbVie Inc.
USD 198.64
ABBV
Roche Holding AG
USD 320.12
RO.SW
AstraZeneca PLC
USD 150.15
AZN.L
Novartis AG
USD 119.03
NOVN.SW
Novo Nordisk A/S
USD 50.00
NOVO-B.CO
Merck & Co., Inc.
USD 80.30
MRK
Thermo Fisher Scientific Inc.
USD 477.41
TMO
Amgen Inc.
USD 284.98
AMGN
Gilead Sciences, Inc.
USD 120.02
GILD
Pfizer Inc.
USD 24.65
PFE
Sanofi
USD 95.31
SAN.PA
Vertex Pharmaceuticals Incorporated
USD 387.77
VRTX
Bristol-Myers Squibb Company
USD 46.55
BMY
Chugai Pharmaceutical Co., Ltd.
USD 42.73
4519.T
Date | Accounts Payable | Short-Term Debt | Long-Term Debt | Total Liabilities |
---|
Eli Lilly and Company
USD 639.43
LLY
AbbVie Inc.
USD 198.64
ABBV
Roche Holding AG
USD 320.12
RO.SW
AstraZeneca PLC
USD 150.15
AZN.L
Novartis AG
USD 119.03
NOVN.SW
Novo Nordisk A/S
USD 50.00
NOVO-B.CO
Merck & Co., Inc.
USD 80.30
MRK
Thermo Fisher Scientific Inc.
USD 477.41
TMO
Amgen Inc.
USD 284.98
AMGN
Gilead Sciences, Inc.
USD 120.02
GILD
Pfizer Inc.
USD 24.65
PFE
Sanofi
USD 95.31
SAN.PA
Vertex Pharmaceuticals Incorporated
USD 387.77
VRTX
Bristol-Myers Squibb Company
USD 46.55
BMY
Chugai Pharmaceutical Co., Ltd.
USD 42.73
4519.T